• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Client Solutions
    • Digital Transformation
    • Energy Transition
    • Supply Chains
    • Sustainability and ESG
    • Workforce Redesign
  • Sectors
    • Consumer Goods & Retail
    • Energy, Mining & Infrastructure
    • Financial Institutions
    • Healthcare & Life Sciences
    • Industrials, Manufacturing & Transportation
    • Technology
  • Learning Resources
    • Podcasts
    • Video Chats
    • Webinars
  • Area of Law
    • Antitrust & Competition
    • Artificial Intelligence
    • Banking & Finance
    • Capital Markets
    • Cybersecurity & Data Privacy
    • Data & Technology
    • Dispute Resolution
    • Employment & Compensation
    • Environment & Climate Change
    • Financial Services Regulatory
    • Inclusion, Diversity & Equity
    • Intellectual Property
    • International Commercial & Trade
    • Investigations, Compliance & Ethics
    • Mergers & Acquisitions
    • Pensions
    • Private Equity
    • Projects
    • Real Estate
    • Restructuring & Insolvency
    • Tax
  • Location
    • International

    • International
    • Asia Pacific

    • Australia
    • China
    • Hong Kong
    • Indonesia
    • Japan
    • Malaysia
    • South Korea (Korea, Republic of)
    • Singapore
    • Taipei
    • Thailand
    • Philippines
    • Vietnam
    • EMEA

    • Austria
    • Bahrain
    • Belgium
    • Czech Republic
    • Egypt
    • EU
    • France
    • Germany
    • Hungary
    • Italy
    • Kazakhstan
    • Luxembourg
    • Morocco
    • Netherlands
    • Poland
    • Portugal
    • Qatar
    • Russian Federation
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Türkiye
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • North America

    • Canada
    • United States
    • Latin America

    • Argentina
    • Brazil
    • Colombia
    • Chile
    • Mexico
    • Peru
    • Venezuela
Baker McKenzie InsightPlus Home
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Client Solutions
    • Digital Transformation
    • Energy Transition
    • Supply Chains
    • Sustainability and ESG
    • Workforce Redesign
  • Sectors
    • Consumer Goods & Retail
    • Energy, Mining & Infrastructure
    • Financial Institutions
    • Healthcare & Life Sciences
    • Industrials, Manufacturing & Transportation
    • Technology
  • Learning Resources
    • Podcasts
    • Video Chats
    • Webinars
  • Area of Law
    • Antitrust & Competition
    • Artificial Intelligence
    • Banking & Finance
    • Capital Markets
    • Cybersecurity & Data Privacy
    • Data & Technology
    • Dispute Resolution
    • Employment & Compensation
    • Environment & Climate Change
    • Financial Services Regulatory
    • Inclusion, Diversity & Equity
    • Intellectual Property
    • International Commercial & Trade
    • Investigations, Compliance & Ethics
    • Mergers & Acquisitions
    • Pensions
    • Private Equity
    • Projects
    • Real Estate
    • Restructuring & Insolvency
    • Tax
  • Location
    • International

    • International
    • Asia Pacific

    • Australia
    • China
    • Hong Kong
    • Indonesia
    • Japan
    • Malaysia
    • South Korea (Korea, Republic of)
    • Singapore
    • Taipei
    • Thailand
    • Philippines
    • Vietnam
    • EMEA

    • Austria
    • Bahrain
    • Belgium
    • Czech Republic
    • Egypt
    • EU
    • France
    • Germany
    • Hungary
    • Italy
    • Kazakhstan
    • Luxembourg
    • Morocco
    • Netherlands
    • Poland
    • Portugal
    • Qatar
    • Russian Federation
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Türkiye
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • North America

    • Canada
    • United States
    • Latin America

    • Argentina
    • Brazil
    • Colombia
    • Chile
    • Mexico
    • Peru
    • Venezuela
  1. Employment & Compensation
  2. Singapore: Intensified enforcement against vaping – implications for foreign nationals

Singapore: Intensified enforcement against vaping – implications for foreign nationals

Enforcement measures for errant offenders include revocation of immigration passes, deportation, and permanent ban from entry into Singapore
19 Sept 2025    3 minute read
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Facebook
    • Google plus
    • Get link
    • Get QR Code
    • Download
    • Print

In brief

Effective 1 September 2025, the Singapore government has launched a Whole-of-Government initiative to address the growing use of e-vaporizers, particularly those containing harmful substances such as etomidate. This multi-agency effort introduces stricter penalties for the possession, use and purchase of e-vaporizers. Enforcement measures have also been significantly intensified, with a particular focus on foreign nationals, including Singapore immigration pass holders and short-term visitors.


Contents

From 1 September 2025:

  • Individuals caught possessing, using or purchasing e-vaporizers will face higher penalties, and recalcitrant users may be required to undergo rehabilitation.
  • Etomidate and its analogues will be classified as Class C controlled drugs under the Misuse of Drugs Act 1973 (MDA) for a period of six months, pending the Ministry of Health’s introduction of a more fit-for-purpose legislation. With this change, individuals who import, sell or distribute e-vaporizers containing etomidate will face prosecution under the MDA and significantly harsher penalties than those currently in place. Those found using etomidate e-vaporizers or who test positive for etomidate will no longer be just subject to fines — they may also face rehabilitation, treatment, mandatory supervision and detention.

We provide below further details with respect to the enforcement measures for foreign nationals — specifically visitors on short-term visit passes and immigration pass holders.

Details

Foreign nationals found in possession of e-vaporizers will have their devices seized and be issued a Notice of Composition (NOC) of SGD 500 for offenders under 18 years old, and SGD 700 for adults. Repeat offenders will face more severe consequences. Short-term visit pass holders who re-offend will be banned from re-entering Singapore upon departure. Immigration pass holders — including, but not limited to, holders of Employment Passes, S Passes, Work Permits, Student’s Passes, Long-Term Visit Passes or Dependant’s Passes — may also have their passes revoked upon a third offence and be deported and permanently barred from re-entering Singapore.

Foreign nationals found in possession of, using, or testing positive for etomidate may have their passes or immigration facilities revoked. They may also face deportation and be permanently barred from re-entering Singapore. Appeals will be considered on a case-by-case basis.

The Singapore government has taken a firm stance against vaping. Recent enforcement actions echo the strict measures the Singapore government took against foreign nationals who did not comply with the relevant measures during the COVID pandemic. In those cases, the noncompliant foreign nationals had their passes cancelled, were deported, and were barred from re-entering Singapore. To avoid potential operational issues, employers are advised to take the following steps:

  • Remind all employees (foreign or otherwise) in Singapore that vaping is illegal in Singapore and that serious disciplinary actions may be meted out if they are caught vaping. For foreign employees working in Singapore, their employment is unlikely to continue if their work pass is cancelled.
  • Remind all travelers to Singapore that vaping is illegal to prevent situations where they may be deported and barred from permanently re-entering the country.
  • Establish anonymous reporting channels for any observed or suspected vaping-related activities to mitigate potential liability and reputational damage.

Employers must ensure that their local and foreign employees, as well as foreign counterparts who frequently travel to Singapore, are well-informed about vaping regulations to avoid any operational disruptions or reputational risks.

* * * * * 

Leong Eng Poh, Senior Paralegal, has contributed to this legal update.

LOGO_Wong&Leow_Singapore

© 2025 Baker & McKenzie. Wong & Leow. All rights reserved. Baker & McKenzie. Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information
Celeste Ang
Principal
Singapore
Read my Bio
celeste.ang@bakermckenzie.com
Kelvin Poa
Principal
Singapore
Read my Bio
kelvin.poa@bakermckenzie.com
Zhao Yang Ng
Principal
Singapore
Read my Bio
zhao.yang.ng@bakermckenzie.com
Averill Chow
Associate
Singapore
averill.chow@bakermckenzie.com

Copyright © 2025 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.

Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content

  •  
  •  
  •  
HighQ
Copyright Baker McKenzie 2025 | Disclaimers | Supplemental Privacy Statement